Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "natural killer"
Too many choices? Use the filter option on the left to narrow your product listing.
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million, with cell type frequency
Catalog #: CC-2703P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
X-VIVOTM 20 Serum-free Hematopoietic Cell Medium
Catalog #: 04-448Q
X-VIVO™ 20, with L-Glutamine, gentamicin and phenol red, xenofree,1 L
X-VIVOTM 20 Serum-free Hematopoietic Cell Medium
Catalog #: BE04-448Q
X-VIVOTM 20, with L-Glutamine, gentamicin and phenol red, xenofree,
1 L
GelStar® Photographic Filter
Catalog #: 50536
Discontinuation notification: Based on our product lifecycle management review to maintain high service levels across our portfolios, this product will be discontinued by end of 2023.
Stepped Neutral Density Plate Recertification Service
Catalog #: 85-011-SND
Stepped Neutral Density Plate Recertification Service (340 and 405 nm)
Stepped Neutral Density Plate Recertification Service
Catalog #: 85-011BA
Stepped Neutral Density Recertification Service - Before and After Testing (340 and 405 nm)
Added to Your Shopping Cart
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
References - X-Vivo™Overview of relevant references
Product Availability by Store Location
Hours